Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
supporting study
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
other: Only abstract available

Data source

Referenceopen allclose all

Reference Type:
publication
Title:
Abstracts Thirty-Third Annual Meeting American College of Clinical Pharmacology October 3-5, 2004, Litchfield Park (Phoenix), Arizona - Prolonged sympathic stimulation with oral choline and urinar yexcretion of histamine and catecholamines in the rat
Author:
Salazar-Rodriguez M, Sosa A, Campos HA
Year:
2004
Bibliographic source:
J Clin Pharmacol 2004 44: 1185/1203
Reference Type:
publication
Title:
Abstracts Thirty-Third Annual Meeting American College of Clinical Pharmacology October 3-5, 2004, Litchfield Park (Phoenix), Arizona -Sympathic stimulation with oral choline fails to increase urinary histamine excretion in spontaneously hypertensive rats
Author:
Sosa A, Salazar-Rodriguez M, Losada M, Campos HA
Year:
2004
Bibliographic source:
J Clin Pharmacol 2004 44: 1185/1203

Materials and methods

Principles of method if other than guideline:
The study originally aimes to examine urinary excretion, determination of toxic effects of the compounds were side-observations. Rats were administered orally by gavage the test compound on three consecutive days.
GLP compliance:
not specified
Test type:
other: 3 d intermittend gavage
Limit test:
no

Test material

Constituent 1
Reference substance name:
Choline
EC Number:
200-535-1
EC Name:
Choline
Cas Number:
62-49-7
IUPAC Name:
2-hydroxy-N,N,N-trimethylethanaminium
Constituent 2
Reference substance name:
choline chloryde
IUPAC Name:
choline chloryde
Constituent 3
Reference substance name:
Choline chloride
EC Number:
200-655-4
EC Name:
Choline chloride
Cas Number:
67-48-1
IUPAC Name:
2-hydroxy-N,N,N-trimethylethanaminium chloride
Test material form:
not specified
Details on test material:
- Name of test material (as cited in study report): choline / choline chloryde

Test animals

Species:
rat
Strain:
other: Sprague-Dawley / spontaneously hypertensive rats (SHR), Sprague-Dawley and Wistar
Sex:
not specified
Details on test animals or test system and environmental conditions:
TEST ANIMALS

Sprague-Dawley rats
- Sex: male
- Weight at study initiation: 300-400 g
- Housing: individually in metabolic cages
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum

Sprague-Dawley / spontaneously hypertensive rats (SHR), Sprague-Dawley and Wistar
- Sex: unknown
- Weight at study initiation: 250-300 g
- Housing: individually in metabolic cages
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
not specified
Details on oral exposure:
Rats were administered orally with destilled water, 4 mL/kg, for 3 days. Days 4, 5 and 6 choline (20 mmole each) in the same volume was administered daily by the same route. Days 7, 8 and 9, water was again administered orally.
Doses:
20 mmole/kg (i.e. 2.79 g/kg bw) each on three consecutive days, resulting in an total amount of 8.37 g/kg bw.
Control animals:
yes
Details on study design:
- Duration of observation period following administration: at least 3 days
- Other examinations performed: urinary analysis

Results and discussion

Effect levelsopen allclose all
Sex:
not specified
Dose descriptor:
LD0
Effect level:
>= 2 790 mg/kg bw
Based on:
test mat.
Remarks on result:
other: given on three consecutive days, hence LD0 can be calculated as intermittent total dose to 8.37 g/kg bw
Sex:
not specified
Dose descriptor:
LD0
Effect level:
>= 3 300 mg/kg bw
Based on:
other: Choline bicarbonate
Remarks on result:
other: re-calculated from LD0 of pure Choline chloride; given on three consecutive days, hence LD0 can be calculated as intermittent total dose to 9.90 g/kg bw
Mortality:
none

Applicant's summary and conclusion

Interpretation of results:
practically nontoxic
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
Although only abstracts are available and hence the reliability is not assessable, the results are consistent with the data provided in the key study, so the LD0 ≥ 3.30 g/kg bw resp. LD0 ≥ 9.90 g/kg (three consecutive days, intermittent gavage) obtained in this study can be used to support the classification of being practically nontoxic as stated in the key study.
Executive summary:

Male Sprague-Dawley rats resp. spontaneously hypertensive rats (SHR), Sprague-Dawley and Wistar rats were administered orally on each three consecutive days 20 mmole (i.e. 2.79 g/kg bw) of of the read-across substance choline chloride, which results in a total, intermittent dose of 8.37 g/kg bw. This dosage corresponds to 3.30 g/kg bw/d and 9.90 g/kg bw choline bicarboante, respectively. No mortalities were observed, so the LD0 was found to be LD0 ≥ 3.30 g/kg bw resp. LD0 ≥ 9.90 g/kg (three consecutive days, intermittent gavage), and hence Choline hydrogen carbonate can be considered to be practically nontoxic.